Skip to main content Skip to navigation

Treat-Nmd Alliance LTD

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

Email Charity

Activities & Mission

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

Is this your charity?

Add your logo, photos and tell the story behind the numbers in your own words. Free for our first 50 launch partners.

Claim this listing Learn more about premium profiles See a sample profile

Areas of Operation

Where this charity is registered to operate, as self-declared to the Charity Commission. These are regulatory classifications, not a list of active programmes, and don't necessarily indicate fundraising activity in each location.

Financial Information

Latest Income
£3,094,584
Latest Expenditure
£3,104,880

Financial Efficiency

Program Ratio 25.0%
% of income going directly to charitable activities
Overall Efficiency 24.9%
% of expenditure going to programs (vs overhead)
Administrative Ratio 75.1%
Overhead (fundraising + governance) as % of total expenditure

Latest Financial Breakdown

Income Sources

Donations & Legacies £0
Charitable Activities £943,565
Other Trading £1,684,821
Investments £8,021
Other Income £458,177

Expenditure Categories

Charitable Expenditure £774,663
Raising Funds £2,330,217
Governance £0
Grants to Institutions £0
Other Expenditure £0

Financial Trend

Annual Returns

As filed with the Charity Commission for England and Wales. Most recent filing covers the financial year ending 2025.

Financial YearIncomeExpenditureCharitable SpendingNet AssetsReservesStaff
2025
£3,094,584
£3,104,880£774,663£826,850£826,85020 / 0
2024
£2,479,051
£2,518,415£253,077£837,146£837,14619 / 0
2023
£2,247,123
£1,892,921£177,005£876,510£876,51015 / 0

Staff column shows: Employees / Volunteers

Frequently asked questions about Treat-Nmd Alliance LTD

What does Treat-Nmd Alliance LTD do?

Treat NMD exists to accelerate treatments to patients with neuromuscular disease, by engaging withpatient advocacy groups, researchers, clinicians, industry and regulators to advance treatments and sharebest practice.

How much income did Treat-Nmd Alliance LTD report in 2025?

Treat-Nmd Alliance LTD reported total income of £3.09m and reported expenditure of £3.10m for the financial year ending 2025, based on the most recent annual return filed with the Charity Commission.

When was Treat-Nmd Alliance LTD registered as a charity?

Treat-Nmd Alliance LTD was registered with the Charity Commission for England and Wales on 20 October 2022 as charity number 1200765. It has been registered for 4 years.

Who runs Treat-Nmd Alliance LTD?

Treat-Nmd Alliance LTD is governed by a board of 3 trustees. The chair of trustees is Dr Kathryn Wagner. Trustees are legally responsible for the charity's governance and are listed in full on its profile.

Where does Treat-Nmd Alliance LTD operate?

Treat-Nmd Alliance LTD operates in England And Wales, as recorded in its Charity Commission filing.

Is Treat-Nmd Alliance LTD a registered charity?

Yes — Treat-Nmd Alliance LTD is a registered charity in England and Wales, charity number 1200765.

Details

Address
TREAT-NMD
One Trinity Gardens
Broad Chare
NEWCASTLE UPON TYNE
NE1 2HF
Registration Date
20 October 2022
Status
Registered

Registry Information

Organisation Number
5204411
Charity Number
1200765

Trustees

Dr Kathryn Wagner Chair
Robert von Rosen
Volker Wilhelm Straub

Data & trust

Register data refreshed
13 October 2026
Report a data issue